{"id":"W2595594504","doi":"10.1200/jco.2012.30.15_suppl.tps8113","title":"ELOQUENT-1: A phase III, randomized, open-label trial of lenalidomide/dexamethasone with or without elotuzumab in subjects with previously untreated multiple myeloma (CA204-006).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Dexamethasone; Multiple myeloma; Internal medicine; Phases of clinical research; Urology; Gastroenterology; Combination therapy; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569576,0.002649952,0.002168239,0.0006325723,0.0005741214,0.00128073,0.001545864,0.002032906,0.006120933],"category_scores_gemma":[0.001010919,0.000780569,0.001171139,0.0004622906,0.001465961,0.001495204,0.0005354969,0.003651564,0.001262711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0014056,"about_ca_system_score_gemma":0.001514561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001507126,"about_ca_topic_score_gemma":0.004207563,"domain_scores_codex":[0.9995302,0.0002365629,0.00001664054,0.00008042226,0.00002887098,0.0001073727],"domain_scores_gemma":[0.9993727,0.0001057407,0.0001266707,0.00003679137,0.00002997594,0.0003281707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.945034,0.02407278,0.001440127,0.0003344673,0.0004708355,0.00009607969,0.00009210764,0.000587705,0.005923206,0.0001920532,0.001909235,0.01984761],"study_design_scores_gemma":[0.9170648,0.07940156,0.001627659,0.00001563081,0.0001601068,0.00004804078,0.00002487828,0.000300143,0.0005093105,0.0001286902,0.000706278,0.00001281807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838282,0.002610019,0.0006606794,0.001163411,0.0004276338,0.0061639,0.002349406,0.0002366188,0.002560234],"genre_scores_gemma":[0.9785776,0.001962985,0.002058362,0.002286096,0.0004840733,0.006912638,0.003316674,0.00004910737,0.004352441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006120933,"threshold_uncertainty_score":0.02047652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2067358223473727,"score_gpt":0.5079667286859392,"score_spread":0.3012309063385664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}